Skip to main content
Premium Trial:

Request an Annual Quote

Fox Chase Starts Personalized Medicine Institute

NEW YORK (GenomeWeb News) – The Fox Chase Cancer Center in Philadelphia has launched the Institute for Personalized Medicine, which will use the center's sample repository and oncology programs along with sequencing to develop personalized chemotherapy approaches.

The IPM will use the center's biosample repository and tumor bank to develop genetic information about individual tumors, and it will incorporate this type of data in its Phase I Clinical Trials Program.

Initially, IPM will use tumor sequencing for "a sizable number of known cancer-related genes," and it will use this genomic information to select appropriate chemotherapy regimens and possibly new drugs being used in the early trials.

The IPM "has the potential to expand dramatically both the pool of available drugs and the list of eligible cancer types," Jeff Boyd, Fox Chase's CSO, said in a statement.

The information about the tumors in the biosample repository will be used to help researchers match tumor types with a pool of new therapeutics that have not been released.

"Instead of simply enrolling patients into Phase I trials who have been treated with and failed to respond to every standard treatment, the information we gain in this project may allow us to determine more accurately which patients should be enrolled into which clinical trial," Roger Cohen, director of Fox Chase's Phase I Clinical Trials Program, said in the statement.

"Of course, this does not just apply to Phase I trials," Cohen said, adding that it "potentially applies to all lines of cancer therapy, including selection of the patient's very first chemotherapy treatment."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.